Not just vaccines: Pfizer sells chametz Israel today

In order to sell the chametz of the international company, the rabbi of Clalit is required to translate the bill of sale into English. • After receiving a power of attorney from the United States, the transaction was completed.

• Pfizer vaccines

  Photo: 

  Gideon Markowitz

A day before Passover, the people of the Pfizer company sold the company's chametz, through a rabbi of Clalit - the largest HMO in Israel, Rabbi Menachem Lepikbeker

The rabbi came to the residence of Rabbi Yitzchak Zilberstein, one of the greatest arbitrators in the ultra-Orthodox community, and sold the chametz of Pfizer and dozens of other international pharmaceutical companies to a non-Jew.

Photo: Courtesy of Clalit Health Insurance Fund

Recently, the company's representatives in Israel expressed interest in selling the chametz, but did so with the approval of the global company.

Rabbi Lefebvre responded to the challenge and translated the chametz sale bill into English so that company executives would understand what they were signing.

After the translation, the management of Pfizer, including the company's CEO Albert Burla, signed a special power of attorney for Clalit's rabbi, who represented them at the chametz sale ceremony.

With a bill from 80 pharmaceutical companies in his possession, today (Thursday) Rabbi Lefkibker arrived with Rabbi Nehemiah Blushtein, director of the Haredi sector in Clalit's Dan district, at the judge's home.

Rabbi Zilberstein, they say, was moved by the sale of chametz by the Pfizer company and congratulated it.

According to Rabbi Lefkibker: "Clalit is a leader in the field of maintaining kosher and halakhah. In the sale of chametz, we are in contact with all the pharmaceutical companies operating in Israel and have been privileged to represent dozens of health bodies around the world in the sale of chametz at Rabbi Zilberstein."